Reimport Bills Would Require “Extraterritorial” Action By FDA – Crawford
Executive Summary
Reimportation laws would force FDA to create an "extraterritorial" enforcement division to ensure the quality of pharmaceuticals intended for shipment to the U.S., Deputy Commissioner Lester Crawford told a Women in Government Relations meeting Oct. 11 in Washington, D.C
You may also be interested in...
Senate Medicaid Supplemental Rebate Amendment May Block PhRMA Suits
An amendment to generic drug legislation in the Senate would eliminate the Pharmaceutical Research & Manufacturers of America's ability to challenge state Medicaid programs' use of supplemental drug rebates for residents not eligible for Medicaid
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials